General & Plastic Surgery Devices - Switzerland

The General & Plastic Surgery Devices market market in Switzerland is anticipated to witness a substantial growth in revenue, with projections indicating a figure of US$263.10m in 2024.
This revenue is expected to exhibit a steady annual growth rate (CAGR 2024-2029) of 4.29%, ultimately leading to a market volume of US$324.70m by 2029.
In a global context, it is noteworthy that the United States is set to generate the highest revenue, with an estimated amount of US$9.84bn in 2024.
Switzerland's demand for advanced and innovative general and plastic surgery devices continues to grow, reflecting the country's commitment to precision and high-quality healthcare.

Definition:
The General & Plastic Surgery Devices market represents medical devices designed for general and plastic surgery procedures, such as disposable surgical supplies, open surgery instruments, minimally invasive surgery instruments.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Johnson & Johnson, Becton Dickinson, Conmed Corporation. Further information on the key players can be found in the Market Shares boxes.

Disposable surgical supplies
Open surgery instruments
Minimally invasive surgery instruments

Services (i.e., treatment expenses)
Blood and transplants derived from the human body
In vitro diagnostics
Diagnostic imaging

The General & Plastic Surgery Devices market in Switzerland is experiencing steady growth due to a combination of customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Switzerland play a significant role in the development of the General & Plastic Surgery Devices market. Swiss consumers are known for their high standards of quality and precision, and they prioritize safety and effectiveness when it comes to medical devices. This has led to an increased demand for technologically advanced and innovative surgical devices that can deliver optimal results with minimal risk. Trends in the market also contribute to the growth of the General & Plastic Surgery Devices market in Switzerland. One notable trend is the rising popularity of minimally invasive procedures. Swiss consumers are increasingly opting for procedures that involve smaller incisions, shorter recovery times, and less scarring. This has created a demand for specialized surgical devices and instruments that can facilitate these procedures. Another trend in the market is the growing focus on personalized medicine. Swiss consumers are seeking customized solutions that can address their specific needs and preferences. This has led to the development of advanced surgical devices that can be tailored to individual patients, resulting in improved outcomes and patient satisfaction. Local special circumstances also play a role in the development of the General & Plastic Surgery Devices market in Switzerland. The country has a well-established healthcare system and a high level of medical expertise. Swiss hospitals and clinics are equipped with state-of-the-art facilities and attract patients from around the world. This creates a demand for advanced surgical devices that can meet the needs of both domestic and international patients. Underlying macroeconomic factors further contribute to the growth of the General & Plastic Surgery Devices market in Switzerland. The country has a strong economy and a high standard of living, which allows consumers to afford elective surgical procedures. Additionally, Switzerland is known for its medical tourism industry, with patients traveling from other countries to receive high-quality medical care. This influx of patients creates a demand for surgical devices and drives market growth. In conclusion, the General & Plastic Surgery Devices market in Switzerland is developing due to customer preferences for quality and safety, trends in the market such as minimally invasive procedures and personalized medicine, local special circumstances including a well-established healthcare system, and underlying macroeconomic factors such as a strong economy and medical tourism.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.